Search results
Beaverton woman awarded $260M from Johnson & Johnson after cancer diagnosis
KOIN via Yahoo News· 2 days agoA woman from Beaverton was awarded $260 million in a lawsuit against Johnson & Johnson, claiming the...
Sleep Easy: 3 Safe Stocks That Won't Have You Stressin'
InvestorPlace· 7 hours agoThe first company’s outstanding profitability highlights its tenacity and potential for long-term...
J&J must pay $260 million in latest talc trial, Oregon jury says
Reuters via Yahoo Finance· 3 days ago(Reuters) -Johnson & Johnson must pay $260 million to an Oregon woman who said she got mesothelioma,...
Johnson & Johnson completes $13.1B acquisition of Shockwave Medical
NJBIZ· 6 days agoJohnson & Johnson completed its $13.1 billion acquisition of Shockwave Medical, a California-based...
Johnson & Johnson At ASCO Highlights Long Term Data From Multiple Myeloma Drug, Shows Sustained...
Benzinga· 3 days agoResults from the MajesTEC-1 study show that, at a median follow-up of 30.4 months, patients treated...
South Africa regulator finds no toxin in recalled cough syrup
Reuters via Yahoo News· 1 day agoJOHANNESBURG (Reuters) -An investigation into two recalled batches of children's cough syrup made in South Africa by Johnson & Johnson found no trace of ...
Osteal raises $50m to bring joint infection drug/device combo to market
Pharmaceutical Technology via Yahoo Finance· 7 hours agoMedtech giant Zimmer Biomet led the round with participation from existing investors, including ...
Johnson & Johnson Ordered To Pay $260M In Latest Talc Trial - Johnson & Johnson (NYSE:JNJ)
Benzinga· 2 days agoA jury has ruled that Johnson & Johnson JNJ must pay $260 million to an Oregon woman who claims to...
Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key Facts
Zacks via Yahoo Finance· 7 days agoJohnson & Johnson (JNJ) closed the latest trading day at $145.28, indicating a +0.58% change from...
RYBREVANT® (amivantamab-vmjw) plus lazertinib is the only chemotherapy-free regimen showing longer...
Tri-County Times· 6 days ago(PRNewsfoto/Johnson & Johnson)